Literature DB >> 31144661

Diagnostic value of blue laser imaging combined with magnifying endoscopy for precancerous and early gastric cancer lesions.

Yang Zhenming1, Shen Lei1.   

Abstract

BACKGROUND/AIMS: Blue laser imaging (BLI) is a new technique for detailed examination of upper gastrointestinal lesions. This study aimed to evaluate the diagnostic value of BLI combined with magnifying endoscopy for precancerous and early gastric cancer lesions.
MATERIALS AND METHODS: A total of 249 gastric lesions detected via conventional white light endoscopy (WLE) based on assessments of mucosal shape and color were included in this study. The accuracy of diagnosis of precancerous or early cancer lesions white light magnification alone, BLI-contrast magnification, and BLI-bright magnification was determined according to the VS criteria.
RESULTS: For white light magnification alone, BLI-contrast magnification, and BLI-bright magnification, the concordance rates for lesions were 76.7%, 85.1%, and 86.7%, respectively, and the Kappa values were 0.571, 0.730, and 0.760, respectively. For the screening of high-grade intraepithelial neoplasia or early gastric cancer, the diagnostic sensitivities of white light magnification alone, BLI-contrast magnification, and BLI-bright magnification were 72.0%, 92.0%, and 92.0%, respectively; the specificities were 95.5%, 98.2%, and 99.1%, respectively; the consistencies were 93.2%, 97.6%, and 98.4%, respectively; and the Kappa values were 0.642, 0.871, and 0.911, respectively. For diagnoses of high-grade intraepithelial neoplasia or early gastric cancer, the concordance between endoscopic and pathological diagnosis was significantly higher for BLI-contrast and BLI-bright magnification than for white light magnification alone (p<0.05).
CONCLUSION: BLI combined with magnifying endoscopy may improve diagnostic accuracy for early gastric cancer and precancerous lesions.

Entities:  

Year:  2019        PMID: 31144661      PMCID: PMC6565344          DOI: 10.5152/tjg.2019.18210

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  3 in total

1.  Rates and Risk Factors for Interval Gastric Cancers at Screening Gastroscopy.

Authors:  Jin Hwa Park; Kang Nyeong Lee; Hang Lak Lee; Dae Won Jun; Jai Hoon Yoon; Oh Young Lee; Byung Chul Yoon; Ho Soon Choi
Journal:  Turk J Gastroenterol       Date:  2021-02       Impact factor: 1.852

2.  A study of evaluating specific tissue oxygen saturation values of gastrointestinal tumors by removing adherent substances in oxygen saturation imaging.

Authors:  Keiichiro Nishihara; Keisuke Hori; Takaaki Saito; Toshihiko Omori; Hironori Sunakawa; Tatsunori Minamide; Masayuki Suyama; Yoichi Yamamoto; Yusuke Yoda; Kensuke Shinmura; Hiroaki Ikematsu; Tomonori Yano
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.240

3.  TRIM50 Inhibits Proliferation and Metastasis of Gastric Cancer via Promoting β-Catenin Degradation.

Authors:  Rongzhou Li; Peng Xu; Xiaosheng Jin; Zhengchao Shi; Qingqing Zhang; Fangpeng Ye; Weilai Yu; Tingting Ji
Journal:  J Oncol       Date:  2022-08-22       Impact factor: 4.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.